Mega Lifesciences PCL (BKK:MEGA-F) 3-Year EBITDA Growth Rate : 9.70% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL 3-Year EBITDA Growth Rate?

Mega Lifesciences PCL's EBITDA per Share for the three months ended in Mar. 2024 was ฿0.72.

During the past 12 months, Mega Lifesciences PCL's average EBITDA Per Share Growth Rate was -4.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 9.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 14.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Mega Lifesciences PCL was 23.80% per year. The lowest was 0.30% per year. And the median was 10.40% per year.

Competitive Comparison of Mega Lifesciences PCL's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mega Lifesciences PCL's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Mega Lifesciences PCL's 3-Year EBITDA Growth Rate falls into.

Mega Lifesciences PCL 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Mega Lifesciences PCL (BKK:MEGA-F) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Mega Lifesciences PCL 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Lifesciences PCL (BKK:MEGA-F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-F) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

MEGA:Thailand

Address

Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea,Bangna, Bangkok, THA, 10260

Website

https://www.megawecare.com

Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast-moving consumer goods as well as the provides distribution services relating to such products. The company's products portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purpose and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL (BKK:MEGA-F) Headlines

No Headlines